ReP USP - Resultado da busca

Filtros : "Financiado pela Fundação Zerbini" "Hypertension" Removido: "OLIVERA, GUSTAVO BALLEJO" Limpar

Filtros

Artigo de periodico
Does obstructive sleep apnea influence blood pressure and arterial stiffness in response to antihypertensive treatment? (2018)
Fatureto-borges, Fernanda; Drager, Luciano Ferreira
Source: Hypertension. Unidade: FM
Subjects: HIPERTENSÃO, PRESSÃO SANGUÍNEA, APNEIA DO SONO, MONITORIZAÇÃO AMBULATORIAL DA PRESSÃO ARTERIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FATURETO-BORGES, Fernanda e DRAGER, Luciano Ferreira. Does obstructive sleep apnea influence blood pressure and arterial stiffness in response to antihypertensive treatment?. Hypertension, v. 72, n. 2, p. 399-407, 2018Tradução . . Disponível em: https://doi.org/10.1161/HYPERTENSIONAHA.118.10825. Acesso em: 02 nov. 2024.
APA
Fatureto-borges, F., & Drager, L. F. (2018). Does obstructive sleep apnea influence blood pressure and arterial stiffness in response to antihypertensive treatment? Hypertension, 72( 2), 399-407. doi:10.1161/HYPERTENSIONAHA.118.10825
NLM
Fatureto-borges F, Drager LF. Does obstructive sleep apnea influence blood pressure and arterial stiffness in response to antihypertensive treatment? [Internet]. Hypertension. 2018 ; 72( 2): 399-407.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1161/HYPERTENSIONAHA.118.10825
Vancouver
Fatureto-borges F, Drager LF. Does obstructive sleep apnea influence blood pressure and arterial stiffness in response to antihypertensive treatment? [Internet]. Hypertension. 2018 ; 72( 2): 399-407.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1161/HYPERTENSIONAHA.118.10825
Artigo de periodico
Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment) (2018)
Krieger, Eduardo M.; Drager, Luciano F.; Lotufo, Paulo A.; Krieger, Jose E.
Source: Hypertension. Unidade: FM
Subjects: HIPERTENSÃO, MONITORIZAÇÃO AMBULATORIAL DA PRESSÃO ARTERIAL, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRIEGER, Eduardo M. et al. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment). Hypertension, v. 71, n. 4, p. 681-690, 2018Tradução . . Disponível em: https://doi.org/10.1161/HYPERTENSIONAHA.117.10662. Acesso em: 02 nov. 2024.
APA
Krieger, E. M., Drager, L. F., Lotufo, P. A., & Krieger, J. E. (2018). Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment). Hypertension, 71( 4), 681-690. doi:10.1161/HYPERTENSIONAHA.117.10662
NLM
Krieger EM, Drager LF, Lotufo PA, Krieger JE. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment) [Internet]. Hypertension. 2018 ; 71( 4): 681-690.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1161/HYPERTENSIONAHA.117.10662
Vancouver
Krieger EM, Drager LF, Lotufo PA, Krieger JE. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment) [Internet]. Hypertension. 2018 ; 71( 4): 681-690.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1161/HYPERTENSIONAHA.117.10662

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024